These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3704991)

  • 1. [Cardiovascular tolerability of indalpine in therapeutic doses].
    Jaillon P; Cheymol G; Alby JM; Ferreri M; Lecocq B
    Therapie; 1986; 41(1):49-52. PubMed ID: 3704991
    [No Abstract]   [Full Text] [Related]  

  • 2. [A cerebellar syndrome and auditory hallucinations in a depressive alcoholic following indalpine treatment].
    Maroy B; Audoin JJ
    Therapie; 1985; 40(2):137. PubMed ID: 4002192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hematologic effects associated with taking indalpine. Cooperative study by French drug surveillance centers].
    Castot A; Efthymiou ML
    Therapie; 1985; 40(5):337-41. PubMed ID: 4095692
    [No Abstract]   [Full Text] [Related]  

  • 4. The cardiovascular toxicity of antidepressants.
    Warrington SJ
    Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():63-70. PubMed ID: 3063746
    [No Abstract]   [Full Text] [Related]  

  • 5. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tricyclic antidepressive drugs should be discontinued preoperatively: contra].
    Jelen-Esselborn S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Jun; 30(4):249-51. PubMed ID: 7632861
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of paroxetine.
    Kuhs H; Rudolf GA
    Psychopharmacology (Berl); 1990; 102(3):379-82. PubMed ID: 2147517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring.
    Smith RC; Chojnacki M; Hu R; Mann E
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):57-63. PubMed ID: 7440526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug flush. Possible role of indalpine overdosage].
    Manigand G; Dumont D; Taillandier J
    Presse Med; 1985 Apr; 14(15):841. PubMed ID: 3158908
    [No Abstract]   [Full Text] [Related]  

  • 10. The problem of side effects: cardiotoxicity.
    Agnoli A; Martucci N; Ciabatti P; Caratozzolo P; Rulli V; Sollecito A
    Adv Biochem Psychopharmacol; 1982; 32():375-81. PubMed ID: 7090903
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating affective disorders in the presence of cardiovascular disease.
    Jefferson JW
    Psychiatr Clin North Am; 1983 Mar; 6(1):141-55. PubMed ID: 6889170
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistant depressions in chronicity phase. Clinical and pharmacological aspects. Apropos of 25 cases].
    Houillon P; Dumont-Girard P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):628-33. PubMed ID: 3833020
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis and pancreatitis due to indalpine].
    Calmus Y; Biour M; Bodin F; Cheymol G; Darnis F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):266-8. PubMed ID: 4007381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3 cases of agranulocytosis during polytherapy including indalpine].
    Laaban JP; Lebras P; Dugay J; Texier F; Vayrac A; Renou P; Ciaudo M; Aimez P; Aubert JP
    Rev Med Interne; 1985 Oct; 6(4):433-5. PubMed ID: 4070852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medifoxamine 50, an antidepressive drug without atropine-like side effects].
    Delaunay J; Meynard J; Elie JC
    Ann Med Psychol (Paris); 1982 Jan; 140(1):148-56. PubMed ID: 7114665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hematologic disorders (acute agranulocytosis) during treatment with indalpine].
    Grosbois B; Milon D; Dauriac C; Leprise PY; Leclech C; Baert A; Beneton C
    Presse Med; 1985 Jan; 14(3):163-4. PubMed ID: 3156348
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of tri- and tetracyclic antidepressive agents on the heart and the cardiovascular system].
    Müller V; Burckhardt D
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1911-3. PubMed ID: 4438988
    [No Abstract]   [Full Text] [Related]  

  • 18. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of the seasons on the course and therapeutic results of depressive phases of maniomelancholy (author's transl)].
    Sedivec V
    Cesk Psychiatr; 1981 Oct; 77(5):326-30. PubMed ID: 7326778
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward depression remission: balancing efficacy and tolerability.
    Montejo AL
    J Clin Psychiatry; 2009 Oct; 70(10):e36. PubMed ID: 19906335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.